JTC-801 alleviates mechanical allodynia in paclitaxel-induced neuropathic pain through the PI3K/Akt pathway.

[1]  N. Staff,et al.  Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems , 2019, Experimental Neurology.

[2]  J. R. Santin,et al.  Pharmacological Treatment of Chemotherapy-Induced Neuropathic Pain: PPARγ Agonists as a Promising Tool , 2019, Front. Neurosci..

[3]  Zongming Jiang,et al.  RETRACTED ARTICLE: Involvement of pro-inflammatory cytokines in diabetic neuropathic pain via central PI3K/Akt/mTOR signal pathway , 2019, Archives of physiology and biochemistry.

[4]  A. V. Braga,et al.  Thiamine, riboflavin, and nicotinamide inhibit paclitaxel-induced allodynia by reducing TNF-α and CXCL-1 in dorsal root ganglia and thalamus and activating ATP-sensitive potassium channels , 2019, Inflammopharmacology.

[5]  S. Negus,et al.  Comparison of Chemotherapy Effects on Mechanical Sensitivity and Food-Maintained Operant Responding in Male and Female Rats , 2019, bioRxiv.

[6]  Mengyuan Zhang,et al.  Antinociceptive and anti-inflammatory effects of cryptotanshinone through PI3K/Akt signaling pathway in a rat model of neuropathic pain. , 2019, Chemico-biological interactions.

[7]  Sang Hoon Lee,et al.  Monoclonal Antibody Targeting the Matrix Metalloproteinase 9 Prevents and Reverses Paclitaxel-Induced Peripheral Neuropathy in Mice. , 2019, The journal of pain : official journal of the American Pain Society.

[8]  S. Abdi,et al.  Losartan, an Angiotensin II Type 1 Receptor Antagonist, Alleviates Mechanical Hyperalgesia in a Rat Model of Chemotherapy-Induced Neuropathic Pain by Inhibiting Inflammatory Cytokines in the Dorsal Root Ganglia , 2019, Molecular Neurobiology.

[9]  Chao Yang,et al.  Duloxetine, a Balanced Serotonin-Norepinephrine Reuptake Inhibitor, Improves Painful Chemotherapy-Induced Peripheral Neuropathy by Inhibiting Activation of p38 MAPK and NF-κB , 2019, Front. Pharmacol..

[10]  J. Palecek,et al.  Mechanical allodynia and enhanced responses to capsaicin are mediated by PI3K in a paclitaxel model of peripheral neuropathy , 2019, Neuropharmacology.

[11]  X. Pang,et al.  Neuroinflammation and central PI3K/Akt/mTOR signal pathway contribute to bone cancer pain , 2019, Molecular pain.

[12]  B. Zhao,et al.  JTC-801 inhibits the proliferation and metastasis of the Hep G2 hepatoblastoma cell line by regulating the phosphatidylinositol 3-kinase/protein kinase B signalling pathway. , 2018, Oncology letters.

[13]  Jing Li,et al.  JTC-801 Suppresses Melanoma Cells Growth through the PI3K‑Akt‑mTOR Signaling Pathways. , 2018, Medecine sciences : M/S.

[14]  Xue Yang,et al.  JTC-801 inhibits the proliferation and metastasis of ovarian cancer cell SKOV3 through inhibition of the PI3K - AKT signaling pathway. , 2018, Pharmazie.

[15]  Y. Tao,et al.  Role of spinal cyclooxygenase‐2 and prostaglandin E2 in fentanyl‐induced hyperalgesia in rats , 2018, British journal of anaesthesia.

[16]  Wei Liu,et al.  PI3K/Akt Pathway is Required for Spinal Central Sensitization in Neuropathic Pain , 2018, Cellular and Molecular Neurobiology.

[17]  Jun Liu,et al.  JTC-801 exerts anti-proliferative effects in human osteosarcoma cells by inducing apoptosis , 2018, Journal of receptor and signal transduction research.

[18]  Shaoyong Wu,et al.  AKAP150 involved in paclitaxel-induced neuropathic pain via inhibiting CN/NFAT2 pathway and downregulating IL-4 , 2018, Brain, Behavior, and Immunity.

[19]  S. Abdi,et al.  Rolipram, a Selective Phosphodiesterase 4 Inhibitor, Ameliorates Mechanical Hyperalgesia in a Rat Model of Chemotherapy-Induced Neuropathic Pain through Inhibition of Inflammatory Cytokines in the Dorsal Root Ganglion , 2017, Front. Pharmacol..

[20]  W. Zeng,et al.  Synergistic Interaction Between Dexmedetomidine and Ulinastatin Against Vincristine-Induced Neuropathic Pain in Rats. , 2017, The journal of pain : official journal of the American Pain Society.

[21]  G. F. Passos,et al.  Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice , 2017, Neuropharmacology.

[22]  J. Xu,et al.  Epigenetic upregulation of CXCL12 expression mediates antitubulin chemotherapeutics–induced neuropathic pain , 2017, Pain.

[23]  Yuguang Huang,et al.  Suppression of MyD88-dependent signaling alleviates neuropathic pain induced by peripheral nerve injury in the rat , 2017, Journal of Neuroinflammation.

[24]  A. Manyande,et al.  PI3K/Akt Pathway: A Potential Therapeutic Target for Chronic Pain. , 2017, Current pharmaceutical design.

[25]  Wan Huang,et al.  Ulinastatin attenuates neuropathic pain induced by L5-VRT via the calcineurin/IL-10 pathway , 2016, Molecular pain.

[26]  Sung Hoon Kim,et al.  Pentoxifylline Ameliorates Mechanical Hyperalgesia in a Rat Model of Chemotherapy-Induced Neuropathic Pain. , 2016, Pain physician.

[27]  Lei Zhang,et al.  Celecoxib reverts oxaliplatin-induced neuropathic pain through inhibiting PI3K/Akt2 pathway in the mouse dorsal root ganglion , 2016, Experimental Neurology.

[28]  I. Utsunomiya,et al.  Paclitaxel-induced peripheral neuropathy increases substance P release in rat spinal cord. , 2016, European journal of pharmacology.

[29]  E. Walters,et al.  Mechanisms involved in the development of chemotherapy-induced neuropathy. , 2015, Pain management.

[30]  Li-na Wang,et al.  MCP-1 stimulates spinal microglia via PI3K/Akt pathway in bone cancer pain , 2015, Brain Research.

[31]  K. Standifer,et al.  Nociceptin/orphanin FQ peptide receptor antagonist JTC‐801 reverses pain and anxiety symptoms in a rat model of post‐traumatic stress disorder , 2015, British journal of pharmacology.

[32]  S. Schulz,et al.  PI3Kγ integrates cAMP and Akt signalling of the μ‐opioid receptor , 2014, British journal of pharmacology.

[33]  J. Pintar,et al.  The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence. , 2014, Pharmacology & therapeutics.

[34]  N. Sundaresan,et al.  Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging. , 2014, Circulation research.

[35]  C. Shapiro,et al.  Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. , 2013, JAMA.

[36]  A. Mori,et al.  Effect of synthetic eel calcitonin, elcatonin, on cold and mechanical allodynia induced by oxaliplatin and paclitaxel in rats. , 2012, European journal of pharmacology.

[37]  S. Lolait,et al.  Role of Nociceptin/Orphanin FQ and NOP Receptors in the Response to Acute and Repeated Restraint Stress in Rats , 2012, Journal of neuroendocrinology.

[38]  Emma E Vincent,et al.  Akt signalling in health and disease. , 2011, Cellular signalling.

[39]  K. Takeda,et al.  Anti-allodynic and anti-hyperalgesic effects of nociceptin receptor antagonist, JTC-801, in rats after spinal nerve injury and inflammation. , 2005, European journal of pharmacology.

[40]  O. Yuge,,et al.  Effect of JTC-801 (nociceptin antagonist) on neuropathic pain in a rat model , 2003, Neuroscience Letters.

[41]  S. Matsumura,et al.  Attenuation of neuropathic pain by the nociceptin/orphanin FQ antagonist JTC‐801 is mediated by inhibition of nitric oxide production , 2003, The European journal of neuroscience.

[42]  Takao Ito,et al.  Pharmacological profiles of a novel opioid receptor‐like1 (ORL1) receptor antagonist, JTC‐801 , 2002, British journal of pharmacology.

[43]  I. Lucki,et al.  Novel Targets to Treat Depression: Opioid-Based Therapeutics. , 2020, Harvard review of psychiatry.

[44]  J. Witkin,et al.  Therapeutic Approaches for NOP Receptor Antagonists in Neurobehavioral Disorders: Clinical Studies in Major Depressive Disorder and Alcohol Use Disorder with BTRX-246040 (LY2940094). , 2019, Handbook of experimental pharmacology.